FDA Warning for Etravirine

被引：0

|

作者：

不详

机构：

来源：

JOURNAL OF DRUGS IN DERMATOLOGY | 2009年 / 8卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

收藏

页码：1050 / 1050

页数：1

相关论文

共 50 条

[31] US FDA issues astemizole warning
Reactions Weekly, 1998, 688 (1) : 2 - 2
[32] FDA lifts olestra warning label
Walsh, K
CHEMICAL WEEK, 2003, 165 (28) : 42 - 42
[33] FDA Warning for Clarcon Skin Products
不详
JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (08) : 777 - 777
[34] FDA issues neuropathy warning on fluoroquinolones
不详
FORMULARY, 2013, 48 (09) : 305 - 305
[35] Tiratricol warning issued by US FDA
Reactions Weekly, 2000, 830 (1) : 3 - 3
[36] FDA issues antidepressant suicide warning
不详
PSYCHIATRIC ANNALS, 2004, 34 (05) : 340 - 340
[37] A Boxed Warning for Montelukast: The FDA Perspective
Clarridge, Katherine
Chin, Stacy
Eworuke, Efe
Seymour, Sally
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (07): : 2638 - 2641
[38] FDA warning of opioid interaction with serotonergics
Reactions Weekly, 2016, 1595 (1) : 2 - 2
[39] No FDA warning label for doxazosin as yet
Reactions Weekly, 2001, 856 (1) : 2 - 2
[40] FDA Calls for Boxed Warning for Metoclopramide
Lang, Les
GASTROENTEROLOGY, 2009, 136 (07) : 2039 - 2039

← 1 2 3 4 5 →